Takeda welcomes the European Commissions proposal for a European Biotech Act and supports its overall ambition to strengthen Europes biotechnology and life sciences ecosystem. The Biotech Act is a positive and necessary step to reinforce Europes position in innovative biotechnologybased medicines.
Takeda Pharmaceuticals International AG
Company · Japan · EU Transparency Register 815176718826-78
Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 925 companies & groups on this site, they rank #885 by legislative files engaged — a count of participation, not a measure of influence.
Declares membership of
- Takeda is a member of European Federation of Pharmaceutical Industries and Associations (EFPIA) and Vaccines Europe.
- Takeda is member of EUCOPE (European Confederation of Pharmaceutical Enterpreneurs).
- Takeda is also member of PPTA Europe, Japanese Business Council in Europe and MedTech Europe.
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).
- Register category
- Companies & groups
- Head office
- Zurich, Switzerland
- EU office
- Brussels
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track Takeda in PolicySpeak: request access →
Work at Takeda Pharmaceuticals International AG? so we know who speaks for it.
Their record over time
Takeda Pharmaceuticals International AG filed 1 position on 4 Aug 2026, across 1 of the 326 legislative files tracked here.
What they argued
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Is this your organization?
Everything on this page comes from Takeda Pharmaceuticals International AG’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.